Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

Phase I study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of TQB3122 capsules in patients with advanced cancer; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB3122

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Cancer | Phase 1 | Status: RECRUITING